[DOI] [PMC free article] [PubMed] [Google Scholar] 66.Wang M.-Y., Ji S.-R., Bai C.-J., El Kebir D., Li H.-Y., Shi J.-M., Zhu W., Costantino S., Zhou H.H., Potempa L.A., et al
Taking L-carnitine without exercising yields minimal fat loss results
doi: 10.1186/s12974-023-02730-z 73 GhoshMGarcia-CastilloDAguirreVGolshaniRAtkinsCMBramlettHMet al
Rx Only Takeda PRINCIPAL DISPLAY PANEL - Kit Carton - 750 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4626-01 Single-dose only For Intravenous Administration After Reconstitution Only Lyophilized powder for reconstitution ADYNOVATE and diluent preassembled in BAXJECT III system Rx Only Actual potency Takeda PRINCIPAL DISPLAY PANEL - Barrel Label - 750 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Directions for use: see package insert Rx Only IU: LOT: EXP: Takeda 6521228 PRINCIPAL DISPLAY PANEL - Blister Label - 750 IU ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] NDC 0944-4626-02 Single-dose only 6521490 For Intravenous Administration Only ADYNOVATE and diluent preassembled in BAXJECT III system Do not open until time of use Do not use if packaging is opened or damaged Discard unused portion
Wyraenie zgody na te technologie umoliwi nam przetwarzanie danych, takich jak zachowanie podczas przegldania lub unikalne identyfikatory na tej stronie
A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications
